Edwards lowers sales forecast
From Times Wire Services
Edwards Lifesciences Corp. lowered its forecast for 2007 sales to the low end of the previous range of $1.07 billion to $1.11 billion.
Earnings will be 41 cents to 43 cents a share in the third quarter and $2.08 to $2.12 for the year, the company said.
Revenue for heart valve therapy sales will be $250 million to $260 million for the second half of the year, according to the company.
Second-quarter profit fell 3.3% to $34.9 million, or 57 cents a share, the Irvine company said. Sales rose 2% to $272.6 million.
